NYMOX PHARMACEUTICAL CORPORATION
NASDAQ : NYMX

NYMOX PHARMACEUTICAL CORPORATION

May 26, 2005 12:02 ET

Newly Published Studies Show Danger of Second Hand Smoke; Nymox -NASDAQ:NYMX- Unique TobacAlert-TM- Product Detects Second-Hand Smoke Exposure; Available Nationwide at over 5400 CVS/pharmacy-R- S

MAYWOOD, N.J.--(CCNMatthews - May 26, 2005) -

The evidence continues to mount about the bad health effects caused by second-hand smoke. According to a special report published in the latest issue of Circulation, the journal of the American Heart Association, the impact of second-hand smoke exposure on the heart and circulatory system is substantial and rapid and nearly as large as actual smoking (Circulation May 24, 2005; 111:2684-2698). Second-hand smoke increases the risk of heart disease by approximately 30%, accounting for at least 35,000 deaths annually in the United States alone, according to the authors at the Center for Tobacco Control Research and Education, Cardiovascular Research Institute, and Division of Cardiology, University of California, San Francisco.

Second-hand smoke exposure also makes it harder for women to get pregnant, according to a study published in the latest issue of Human Reproduction. Researchers from McMaster University in Canada found the pregnancy rate for women exposed to second-hand smoke was less than half than that of non-smokers and almost exactly the same as actual smoking. The study followed a group of 225 women undergoing in-vitro fertilization.

Nymox's TobacAlert™ product provides an easy, cost-effective means of detecting second-hand smoke exposure. TobacAlert™ can be used at home, at school or in the workplace. No instruments are required and results are provided within minutes. TobacAlert™ measures the level of cotinine, a metabolite of nicotine, in urine. Cotinine is widely accepted and commonly used in medical research and public health studies to determine the extent of tobacco product use or exposure.

TobacAlert™ is available at over 5,400 CVS/pharmacy® stores across the U.S. as well as online at http://www.cvs.com. More information is available at http://www.tobacalert.com.

The ability of Nymox's tobacco exposure testing technology to measure second-hand smoke exposure has been successfully put to the test by reporters, as reported recently in the New York Daily News "Guinea Pig" column (April 27, 2005) and earlier in the London Sunday Telegraph (January 25, 2004) and Melbourne, Australia's The Sunday Herald Sun (June 26, 2004).

More information about Nymox is available at http://www.nymox.com, email: info@nymox.com, or 800-936-9669.

This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.

Contact Information